← Leaderboards
Mark A. Stidham
Trius Therapeutics, Inc.
$8,680,866
Attributed
$8,680,866
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$8,680,866 · 1
By mechanism
N01$8,680,866 · 1
Top collaborators
No co-investigators on record.
Most similar at Trius Therapeutics, Inc.
Same institution · by research overlap
- Mark Alan Stidham$1,205,225
- John Finn$3,924,166
Others in their field
Top investigators on “Advanced Development”
- David Heimbrook · Leidos Biomedical Research, Inc.$625,894,719
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$331,630,794
- David H Reitze · University Of Florida$318,606,363
- Albert Lazzarini · California Institute Of Technology$317,303,333
Research focus
Advanced DevelopmentAnti-Bacterial AgentsBiodefenseContractsPathogenPre-ClinicalProduct DevelopmentSupport Contracts